Prioritization of cancer therapeutic targets using CRISPR–Cas9 screensFiona M. Behan, Mathew J. Garnett, Dieudonne van der Meer et al.|Nature|2019Cited by 1.4k
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid LeukemiaKonstantinos Tzelepis, Kosuke Yusa, Hiroko Koike-Yusa et al.|Cell Reports|2016Cited by 834
Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data setsJoshua M. Dempster, Francesco Iorio, Clare Pacini et al.|Nature Communications|2019Cited by 281
Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targetingFrancesco Iorio, Mathew J. Garnett, Fiona M. Behan et al.|BMC Genomics|2018Cited by 144
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screeningGabriele Picco, Mathew J. Garnett, Elisabeth Chen et al.|Nature Communications|2019Cited by 134